Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cow's milk allergens are a heterogeneous group of proteins found in bovine milk that trigger immune-mediated hypersensitivity reactions, collectively known as cow's milk allergy (CMA). These allergens are categorized into two main fractions: caseins, which include alpha-s1, alpha-s2, beta, and kappa-caseins (Bos d 8-12), and whey proteins, such as alpha-lactalbumin (Bos d 4) and beta-lactoglobulin (Bos d 5). These proteins are highly stable and resistant to heat and proteolytic digestion, allowing them to maintain their allergenicity within the gastrointestinal tract. CMA is one of the most prevalent food allergies in early childhood, presenting with symptoms ranging from mild urticaria and gastrointestinal distress to severe, life-threatening anaphylaxis. While the standard of care has traditionally been strict dietary avoidance, these allergens are now utilized as the active pharmaceutical ingredients in oral immunotherapy (OIT) to induce clinical desensitization. In such therapies, the allergens are administered in gradually increasing doses to modulate the patient's immune system toward a state of tolerance, often in combination with adjunctive biological therapies like omalizumab or dupilumab to mitigate allergic side effects.
Induction of oral tolerance through gradual desensitization of the immune system by controlled exposure to the allergens (Oral Immunotherapy).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cow's milk allergens (CMA).